You are offline. Saved alerts are still available. Live updates resume when you reconnect.
Reading a stock page
- The tabs show the price chart, results, shareholding, events and news for this one company.
- The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
- Every figure names its source. "Official" means it came from NSE or BSE filings.
- Use the star to watch the stock, or Add to portfolio to record a trade.
🎯 Buy It or Not? — Complete Intraday to Long-Term Decision Report for ASTRAZEN (BSE)
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
43
ISA Signal Score: Weak
Trend0
Momentum31
52-week range12
Volume69
Risk64
Fundamentals91
Working for it
- Profit grew 63% year on year
- Revenue grew 29% year on year
- Low debt
Working against it
- Price is below its 20-day average
- Price is below its 50-day average
- Price is below its 200-day average (long-term weakness)
- 50-day average is below the 200-day average
- 50-day average is falling
- MACD is negative and weakening
Red flags
- Thinly traded: average daily turnover is low, so entering or exiting can be hard
At a glance
QualityStrongROE 24.8%, ROCE 33.4%, almost no debt
GrowthNot knownNeeds at least 3 years of results. More years load on later visits.
ValuationExpensiveP/E 94.7 vs sector median 44.6, 21.5x book
MomentumWeakBelow its 200-day average, lagged NIFTY 50 by 30.8 points
RiskLowSwings 23% a year, fell up to 38% from a peak, beta 0.56
Smart Investor Tips: ASTRAZEN
Balanced / Watch for Key Level ConfirmationActionable Insights & Positives
- Strong earnings compounding: net profit grew at 62.7% CAGR over 1 years.
- High capital efficiency: ROE of 24.8% indicates strong returns on shareholder equity.
- Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.
Risk Checks & Things to Verify
- Long-term downtrend: price is below its 200-day average (Rs 7,786.92). Wait for a base formation and reclaim of the 50-day average (Rs 6,295.64) before committing fresh capital.
- Premium valuation: P/E of 94.7x vs sector median 44.6x leaves less margin of safety if growth slows.
BSE Authentic Bhavcopy & Cross-Exchange Check No API Key
Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 64/100)
Consolidating. If buying, accumulate only on dips into support at Rs 5,660.00 – Rs 6,120.45 (Ideal ~Rs 5,890.23). Review if price closes below Rs 5,327.47; upside resistance near Rs 6,903.20.
| Optimal Support area | Tranche 1 (50%) | Tranche 2 (50%) | Risk level / Review | Level 1 (Swing) | Level 2 (Breakout) | Risk : Reward |
|---|---|---|---|---|---|---|
| Rs 5,660.00 – Rs 6,120.45 Ideal ~Rs 5,890.23 |
Rs 6,120.45 | Rs 5,660.00 | Rs 5,327.47 ATR 3.6% |
Rs 6,903.20 | Rs 9,449.00 | 1 : 1.8 RSI 44 · Vol 1.47x |
Live Candlestick & TradingView Chart (ASTRAZEN)
MARKET CLOSED - EOD SNAPSHOTKey figures
P/E94.7sector median 44.6
P/B21.49xprice / book value
EPSRs 64.60grew 62.6% a year
Dividend yield-from saved dividend events
Debt to equity0.00xmore cash than debt
Sales growth29.2%a year over 1 years
Profit growth62.7%a year over 1 years
Operating margin15.5%net margin 12.5%
Company Debt, Borrowings & Cash Flow Health
Total Debt / Loans
Rs 0 Cr
Reduced Rs 0 Cr YoY
Cash & Bank Balances
Rs 506 Cr
Liquid cash & equivalents
Net Debt (Loans − Cash)
Net Cash Rs 506 Cr
Debt-free on net basis
Debt to Equity & Interest Cover
0.00x D/E
Interest cover: 184.0x EBIT
Operating Cash Flow (OCF)
Rs 92.5 Cr
OCF/PAT conversion: 57%
Free Cash Flow (FCF)
Rs 81.8 Cr
After Capex of Rs 10.8 Cr
About ASTRAZENECA PHARMA INDIA
Market capNot available
First listed04 May 2001BSE not available · NSE 04 May 2001
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed
Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE
Shareholding
Promoters and group 75.00% 0.00 pp, public 25.00%, as on 30 Sep 2026. Holder names and history
Day range5,990.00 to 6,154.75Open 6,046.00
52-week high9,255.00
-33.9% from high (08 Dec 2025)
52-week low5,660.00
+8.1% from low (09 Oct 2026)
Volume631
1.1x the 20-day average
RSI (14)45
neutral
Volatility (30d)29.6%annualised
Returns
1W-4.8%
1M+1.3%
3M-18.4%
6M-28.7%
1Y-32.9%
YTD-32.1%
3Y a year+9.6%
5Y a year+14.6%
Against the NIFTY 50
| Period | ASTRAZEN | NIFTY 50 | Difference |
|---|---|---|---|
| 1M | +1.3% | +11.5% | -10.2 pts |
| 3M | -18.4% | +5.3% | -23.7 pts |
| 6M | -28.7% | +7.9% | -36.5 pts |
| 1Y | -32.9% | -2.1% | -30.8 pts |
Risk over the past year
Volatility23%low
Deepest fall-38.1%from a peak
Beta0.56moves less than the index
Best day+5.1%13 Apr 2026
Worst day-6.1%13 Nov 2026
Up days45%of sessions
🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition
Piotroski F-Score: 8 / 9 · Fortress Balance Sheet
3-Step DuPont ROE Identity:
High Asset-Velocity & Turnover Compounder
Net Margin: 12.5%
×
Asset Turnover: 1.20x
×
Equity Multiplier: 1.51x
=
ROE 24.8%
✓ Positive Net Profit (PAT > 0)
Rs 162 Cr
✓ Positive Operating Cash Flow (OCF > 0)
Rs 92.5 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT)
57% conversion
✓ Improving Return on Assets (ROA YoY)
15.0% vs 10.1%
✓ Conservative / Decreasing Debt-to-Equity
0.00x (prev 0.00x)
✓ Healthy Balance Sheet Asset Coverage
3.02x
✓ Institutional Return on Equity (ROE >= 14%)
24.8%
✓ Stable / Expanding Profit Margin YoY
12.5% vs 9.9%
✓ Asset Turnover Efficiency (Sales / Assets)
1.20x
Quarterly Results (Last 5 Quarters — QoQ & YoY Acceleration)
| Rs crore | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| Sales / Revenue | 306 | 383 | 388 | 408 | 440 |
| Sales QoQ % | - | +25.3% | +1.1% | +5.3% | +7.9% |
| Operating Profit | 15.1 | 49.4 | -19.5 | 52.5 | 43.4 |
| Operating Margin (OPM %) | 4.9% | 12.9% | -5.0% | 12.9% | 9.9% |
| Net Profit (PAT) | 15.8 | 39.5 | -11.8 | 38.4 | 30.9 |
| Profit QoQ % | - | +149.9% | -129.9% | +426.0% | -19.7% |
| Profit YoY % | - | - | - | - | +95.3% |
| Net Margin % | 5.2% | 10.3% | -3.0% | 9.4% | 7.0% |
Sales and profit
Sales growth+29.2%a year, 1Y
Profit growth+62.7%a year, 1Y
EPS growth+62.6%a year, 1Y
Avg ROE20.9%2 years
Profit and loss
| Rs crore | FY23 | FY24 |
|---|---|---|
| Sales | 1,003 | 1,296 |
| Sales growth | - | +29.2% |
| Operating profit | 125 | 201 |
| Operating margin | 12.5% | 15.5% |
| Other income | 26.1 | 34.8 |
| Interest | 0.63 | 1.20 |
| Depreciation | 16.3 | 14.9 |
| Profit before tax | 134 | 220 |
| Tax rate | 26.0% | 26.4% |
| Net profit | 99.3 | 162 |
| Profit growth | - | +62.7% |
| Net margin | 9.9% | 12.5% |
| EPS (Rs) | 39.72 | 64.60 |
Balance sheet
| Rs crore | FY23 | FY24 |
|---|---|---|
| Equity (net worth) | 589 | 712 |
| Borrowings | 0 | 0 |
| Cash | 500 | 506 |
| Total assets | 985 | 1,078 |
| Debt to equity | 0.00x | 0.00x |
Debt, Loans, Cash Flow & Working Capital
| Rs crore | FY23 | FY24 |
|---|---|---|
| Operating Cash Flow (OCF) | 58.3 | 92.5 |
| Capital Expenditure (Capex) | 8.52 | 10.8 |
| Free Cash Flow (FCF = OCF - Capex) | 49.8 | 81.8 |
| OCF / Net Profit Conversion | 0.59x | 0.57x |
| Total Borrowings / Loans | 0 | 0 |
| Cash & Bank Balances | 500 | 506 |
| Trade Receivables (Cr) | 108 | 153 |
| Receivable Days | 39.13x | 43.14x |
| Inventories (Cr) | 190 | 228 |
| Inventory Days | 69.22x | 64.20x |
Returns on capital
| Rs crore | FY23 | FY24 |
|---|---|---|
| ROE | 16.9% | 24.8% |
| ROCE | 22.4% | 33.4% |
| Interest cover | 213.86x | 183.95x |
Compared with its sector Pharma & Healthcare
| Stock | Price | Day | 1 year | Mkt cap (Cr) | P/E | P/B | ROE | Net margin |
|---|---|---|---|---|---|---|---|---|
| ALIVUSALIVUS LIFE SCIENCES LIMITED | 1,449.85 | +0.3% | - | 17,768 | 37.7 | 7.6 | 20.2% | 20.6% |
| CAPLIPOINTCAPLIN POINT LABORATORIES LTD. | 2,085.40 | -0.0% | - | 15,839 | 34.6 | 6.8 | 19.7% | 27.0% |
| ASTRAZENASTRAZENECA PHARMA INDIA LTD. | 6,120.45 | +1.9% | - | 15,301 | 94.7 | 21.5 | 22.7% | 12.5% |
| AARTIPHARMAarti Pharmalabs Limited | 1,024.80 | +1.3% | - | 9,287 | 42.8 | 5.3 | 12.3% | 11.7% |
| BLUEJETBlue Jet Healthcare Limited | 516.80 | -0.2% | - | 8,964 | 54.7 | 10.6 | 19.4% | 23.0% |
| CIPLACIPLA LTD. | 1,416.00 | -0.3% | - | - | 29.5 | - | - | 13.7% |
| ALKEMAlkem Laboratories Limited | 5,145.00 | -1.1% | - | - | 26.7 | - | 17.0% | 16.0% |
| DIVISLABDIVIS LABORATORIES LTD. | 11,178.00 | +1.0% | - | - | 115.6 | - | 15.3% | 24.3% |
| WOCKPHARMAWOCKHARDT LTD. | 2,186.60 | +7.9% | - | - | - | - | - | - |
| RUBICONRUBICON RESEARCH LIMITED | 1,726.00 | +3.9% | - | - | - | - | - | - |
| APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT | 8,744.80 | -0.8% | - | - | 64.8 | - | 21.1% | 7.9% |
| RAINBOWRainbow Children's Medicare Li | 1,241.45 | -1.3% | - | - | - | - | - | - |
| Sector median | - | 44.6 | 7.6 | 17.0% |
Today: 15 minute chart and signal
Analysis and next-session reading
Signals
Price is below its 50-day average
20-day average is below the 50-day (short-term downtrend)
Price is below its 200-day average (long-term downtrend)
RSI 45: neutral
When is a good price?
The price is in the lower quarter of its 1-year range and is lower than it was on 91% of days in the past year.
Support (prices below today's)
| 20-day low | 5,860.00 | -4.3% |
| 60-day low | 5,660.00 | -7.5% |
| 52-week low | 5,660.00 | -7.5% |
Resistance (prices above today's)
| 50-day average | 6,295.64 | +2.9% |
| 20-day high | 6,800.00 | +11.1% |
| 60-day high | 7,449.70 | +21.7% |
| 200-day average | 7,786.92 | +27.2% |
Zones buyers often watch
| Lower quarter of the 1-year range | 5,660.00 to 6,558.75 | price is inside this zone now |
| Pullback of 10% to 20% from the high | 7,404.00 to 8,329.50 | A common area for dips inside an uptrend. |
| Around the 200-day average | 7,553.32 to 8,020.53 | Long-term trend line, often watched as support. |
Moving averages and momentum
| Indicator | Value | Reading |
|---|---|---|
| 20-day average | 6,231.32 | Price is 1.8% below |
| 50-day average | 6,295.64 | Price is 2.8% below |
| 200-day average | 7,786.92 | Price is 21.4% below |
| RSI (14) | 45 | Neutral |
| MACD (12, 26, 9) | -40.14 | Below its signal line (momentum fading) |
| Volatility (30d) | 29.6% | Medium yearly swings |
Support and resistance
R26,253.15
R16,186.80
Pivot6,088.40
S16,022.05
S25,923.65
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| 2026-11-19 | 6,046.00 | 6,154.75 | 5,990.00 | 6,120.45 | +1.89% | 631 |
| 2026-11-18 | 6,155.05 | 6,389.00 | 5,967.95 | 6,006.95 | -2.58% | 692 |
| 2026-11-17 | 6,020.05 | 6,200.00 | 5,970.00 | 6,166.20 | +2.21% | 394 |
| 2026-11-16 | 6,038.05 | 6,070.00 | 5,910.00 | 6,032.75 | -0.10% | 1,160 |
| 2026-11-13 | 6,399.05 | 6,399.05 | 6,000.00 | 6,039.00 | -6.10% | 1,003 |
| 2026-11-12 | 6,537.05 | 6,548.75 | 6,420.00 | 6,431.20 | -1.23% | 497 |
| 2026-11-11 | 6,589.40 | 6,605.80 | 6,480.70 | 6,511.10 | -0.02% | 205 |
| 2026-11-09 | 6,499.25 | 6,540.35 | 6,392.90 | 6,512.20 | +0.50% | 545 |
| 2026-11-06 | 6,308.15 | 6,800.00 | 6,290.45 | 6,387.90 | +1.48% | 2,792 |
| 2026-11-05 | 6,532.95 | 6,532.95 | 6,205.00 | 6,294.90 | -1.10% | 180 |
| 2026-11-04 | 6,350.00 | 6,399.00 | 6,350.00 | 6,365.10 | +0.39% | 172 |
| 2026-11-03 | 6,319.00 | 6,353.55 | 6,295.30 | 6,340.60 | +0.91% | 104 |
| 2026-11-02 | 6,383.25 | 6,445.95 | 6,255.00 | 6,283.25 | -1.32% | 396 |
| 2026-10-30 | 6,257.50 | 6,383.20 | 6,250.00 | 6,367.35 | +1.10% | 119 |
| 2026-10-29 | 6,190.05 | 6,319.95 | 6,161.00 | 6,298.05 | +1.02% | 410 |
| 2026-10-28 | 6,058.50 | 6,385.00 | 6,058.50 | 6,234.70 | +2.66% | 1,034 |
| 2026-10-27 | 6,005.05 | 6,100.00 | 5,995.00 | 6,073.10 | -0.03% | 120 |
| 2026-10-26 | 6,039.10 | 6,112.80 | 5,890.30 | 6,074.75 | +1.45% | 266 |
| 2026-10-23 | 6,035.20 | 6,035.20 | 5,860.00 | 5,988.15 | -1.81% | 288 |
| 2026-10-22 | 6,068.05 | 6,124.00 | 6,000.00 | 6,098.65 | +0.36% | 199 |
| 2026-10-21 | 6,011.05 | 6,130.85 | 5,971.20 | 6,076.90 | +0.56% | 1,073 |
| 2026-10-19 | 5,925.00 | 6,078.40 | 5,850.00 | 6,043.30 | +1.29% | 177 |
| 2026-10-16 | 5,930.00 | 5,985.10 | 5,860.50 | 5,966.05 | +0.73% | 117 |
| 2026-10-15 | 5,900.65 | 6,000.00 | 5,879.30 | 5,922.60 | -0.35% | 292 |
| 2026-10-14 | 5,850.05 | 5,955.00 | 5,839.00 | 5,943.50 | +0.96% | 299 |
| 2026-10-13 | 5,920.00 | 5,932.75 | 5,800.00 | 5,887.00 | -0.57% | 460 |
| 2026-10-12 | 5,860.05 | 5,930.85 | 5,833.95 | 5,920.60 | +1.52% | 152 |
| 2026-10-09 | 5,726.00 | 5,860.50 | 5,660.00 | 5,831.85 | +2.24% | 727 |
| 2026-10-08 | 5,918.60 | 5,918.60 | 5,669.10 | 5,704.05 | -3.62% | 842 |
| 2026-10-07 | 6,019.50 | 6,019.50 | 5,805.00 | 5,918.55 | -1.08% | 826 |
| 2026-10-06 | 5,913.05 | 5,994.80 | 5,888.25 | 5,983.25 | +1.19% | 474 |
| 2026-10-05 | 6,078.15 | 6,087.30 | 5,889.10 | 5,913.00 | -1.95% | 269 |
| 2026-10-01 | 6,133.00 | 6,154.05 | 5,977.60 | 6,030.45 | -2.56% | 995 |
| 2026-09-30 | 6,225.65 | 6,280.00 | 6,130.00 | 6,188.75 | -1.05% | 593 |
| 2026-09-29 | 6,308.25 | 6,350.00 | 6,217.50 | 6,254.35 | -0.53% | 403 |
| 2026-09-28 | 6,490.85 | 6,490.85 | 6,267.25 | 6,287.50 | -3.53% | 912 |
| 2026-09-25 | 6,600.00 | 6,661.00 | 6,444.00 | 6,517.85 | -1.08% | 969 |
| 2026-09-24 | 6,678.80 | 6,701.00 | 6,562.75 | 6,588.90 | -1.79% | 466 |
| 2026-09-23 | 6,685.55 | 6,730.00 | 6,650.05 | 6,709.20 | -0.04% | 341 |
| 2026-09-22 | 6,663.90 | 6,742.00 | 6,606.30 | 6,712.15 | +0.72% | 342 |
| 2026-09-21 | 6,709.80 | 6,784.00 | 6,624.00 | 6,663.90 | -1.30% | 128 |
| 2026-09-18 | 6,610.00 | 6,772.65 | 6,610.00 | 6,751.40 | +1.15% | 402 |
| 2026-09-17 | 6,710.80 | 6,719.90 | 6,650.15 | 6,674.55 | -0.54% | 249 |
| 2026-09-16 | 6,751.00 | 6,881.65 | 6,656.30 | 6,710.80 | +0.26% | 541 |
| 2026-09-15 | 6,736.00 | 6,790.50 | 6,621.00 | 6,693.35 | -1.36% | 1,195 |
| 2026-09-11 | 6,858.70 | 6,858.70 | 6,760.90 | 6,785.35 | -1.07% | 463 |
| 2026-09-10 | 6,900.00 | 6,900.00 | 6,842.80 | 6,858.65 | -0.59% | 172 |
| 2026-09-09 | 6,864.80 | 6,914.80 | 6,810.00 | 6,899.30 | +0.50% | 482 |
| 2026-09-08 | 6,860.05 | 6,933.45 | 6,827.35 | 6,864.80 | +0.16% | 642 |
| 2026-09-07 | 6,917.00 | 6,964.60 | 6,815.30 | 6,853.70 | -1.11% | 473 |
| 2026-09-04 | 6,940.00 | 7,060.00 | 6,901.20 | 6,930.80 | -0.23% | 784 |
| 2026-09-03 | 6,854.50 | 6,975.05 | 6,850.05 | 6,946.95 | +1.12% | 516 |
| 2026-09-02 | 6,885.00 | 6,895.00 | 6,832.15 | 6,870.25 | -0.82% | 646 |
| 2026-09-01 | 6,900.10 | 7,024.95 | 6,900.10 | 6,927.10 | -0.63% | 376 |
| 2026-08-31 | 7,050.00 | 7,100.00 | 6,905.00 | 6,970.75 | -1.91% | 371 |
| 2026-08-28 | 7,131.60 | 7,158.25 | 7,081.00 | 7,106.25 | -0.21% | 139 |
| 2026-08-27 | 7,155.45 | 7,196.00 | 7,075.00 | 7,121.10 | -0.48% | 617 |
| 2026-08-26 | 7,230.00 | 7,245.45 | 7,140.00 | 7,155.45 | -0.15% | 431 |
| 2026-08-25 | 7,298.55 | 7,298.55 | 7,120.00 | 7,166.30 | -0.74% | 747 |
| 2026-08-24 | 7,400.05 | 7,449.70 | 7,194.05 | 7,220.05 | -2.57% | 1,697 |
| 2026-08-21 | 7,580.50 | 7,580.50 | 7,380.00 | 7,410.50 | -1.25% | 576 |
| 2026-08-20 | 7,519.45 | 7,613.00 | 7,480.20 | 7,504.30 | -0.05% | 508 |
| 2026-08-19 | 7,610.25 | 7,648.95 | 7,490.00 | 7,508.20 | -1.85% | 533 |
| 2026-08-18 | 7,680.85 | 7,750.70 | 7,595.00 | 7,649.85 | +0.28% | 144 |